Clinical Trials Logo

Neurogenic Bladder clinical trials

View clinical trials related to Neurogenic Bladder.

Filter by:
  • Active, not recruiting  
  • Page 1

NCT ID: NCT06247033 Active, not recruiting - Stroke Clinical Trials

Efficacies of Different Managements in Patients With Overactive Bladder With Stroke

Start date: November 1, 2022
Phase: N/A
Study type: Interventional

The goal of this clinical trial is to comparing the efficacies of different managements in patients with overactive bladder symptoms with stroke The main question it aims to answer are: - Are pelvic floor training exercises and bladder training enough to ease the symptoms of overactive bladder in patients with stroke? - Is tibial nerve stimulation really effective and does it decrease the need of medications in patients with overactive bladder with stroke? Participants are questioned if they have the symptoms of overactive bladder. After urodynamic evaluation, they are separated in 2 groups. Pelvic floor training exercises and bladder training are given in both groups; while one of the groups is followed with tibial nerve stimulation and the other one is followed with sham tibial nerve stimulation for 6 weeks. Our main aim was to compare effectiveness of tibial nerve stimulation in patiens with overactive bladder with stroke.

NCT ID: NCT05502614 Active, not recruiting - Clinical trials for Spinal Cord Injuries

Dorsal Genital Nerve Stimulation for Bladder Management After SCI

NEUROMOD UCon
Start date: January 23, 2023
Phase: N/A
Study type: Interventional

Following spinal cord injury signals between the brain and the bladder are disrupted. As a result the bladder often becomes overactive which can lead to the need for frequent trips to the toilet, regular incontinence episodes and a decreased quality-of-life. Neuromodulation is a therapy that aims to target the nerves that become overactive controlling the bladder, stopping the bladder overactivity on demand using an external (non-invasive) nerve stimulation box and sticker electrodes placed on the penis or clitoris. This study is a pilot study that aims to investigate neuromodulation for improving symptoms of bladder overactivity when used by 10 people over eight weeks at home. We will assess whether using the device improves bladder capacity, incontinence, frequency of needing the toilet and whether there are any longer lasting changes after 8 weeks. Finally, the study will aim to find out the acceptability of using this type of therapy for participants and the acceptability of the device we are using. Participants in this trial will participate over 13 weeks and need to visit our centre in Stanmore to have urodynamics tests in the 1st, 9th and 13th week. At home they will use a small stimulation device on a daily basis for 8 weeks to control overactivity in the bladder. Whilst at home they will record relevant outcomes in several three-day diaries and questionnaires. They will record baseline data before starting stimulation and for 4 weeks after.

NCT ID: NCT04922437 Active, not recruiting - Neurogenic Bladder Clinical Trials

Implantation of Continent Catheterizable Channel : Native Bladder or Enterocystoplasty ?

ICODE
Start date: January 1, 2020
Phase:
Study type: Observational

PURPOSE. To compare the results between two sites of implantation of the continent catheterizable channel (CCC): native bladder or enterocystoplasty. METHODS. Retrospective monocentric study of pediatrics and adult patients who underwent a continent cystostomy between 1991 and 2020 with a continent catheterizable channel implanted in the native bladder's detrusor (D group) or the enterocystoplasty (EC group).

NCT ID: NCT03931408 Active, not recruiting - Clinical trials for Spinal Cord Injuries

Gentamicin Bladder Instillation in Individuals With Spinal Cord Injury Having Chronic Urinary Tract Infections

Start date: February 19, 2019
Phase: Phase 2
Study type: Interventional

Participants will undergo daily gentamicin bladder instillations to determine if its use will reduce the rate of symptomatic urinary tract infections (UTIs) as well as the use of oral and intravenous antibiotics in adults with chronic spinal cord injury (SCI) who have recurrent UTIs. Participants are randomized into one of three groups: 1) Gentamicin and saline instillation 2) Saline only instillation 3) Standard of care, no instillation.

NCT ID: NCT03559036 Active, not recruiting - Clinical trials for Spinal Cord Injuries

Pediatric Locomotor Training Bladder Study

Start date: April 26, 2018
Phase:
Study type: Observational

Bladder dysfunction is one of the most important factors influencing duration and quality of life in children with spinal cord injury. Effective bladder control comprises a major aspect of a child's life with SCI and is especially challenging due to the rapid changes in a child's physical and cognitive development. Urological consequences secondary to a neurogenic bladder are responsible for many clinical complications post-spinal cord injury, including repeated urinary tract infections, autonomic dysreflexia, lifelong urologic care, and many hospitalizations. Alternative approaches to bladder management that focus on recovery of function and age-appropriate independence are needed. Prior research findings in our lab in adult participants indicate a benefit of locomotor training on bladder function. The purpose of this study is to determine with quantitative unbiased urodynamic outcome measures if locomotor training, provided to children with spinal cord injury, impacts the developing urinary system.

NCT ID: NCT03503513 Active, not recruiting - Clinical trials for Spinal Cord Injuries

Gentamicin Bladder Instillations to Prevent Urinary Tract Infections in Patients With Spinal Cord Injury

Start date: August 24, 2018
Phase: Phase 2/Phase 3
Study type: Interventional

A non-randomized study evaluating the efficacy of intravesical gentamicin on the occurrence rate of urinary tract infections and bladder complications in patients after spinal cord injury (SCI), and to assess its effectiveness in promoting overall quality of life (QOL), community living, and participation.

NCT ID: NCT00602186 Active, not recruiting - Neurogenic Bladder Clinical Trials

Effect of Tamsulosin vs Prazosin in Treatment of Female Voiding Dysfunction

Start date: July 2005
Phase: Phase 1/Phase 2
Study type: Interventional

The purpose of this study is to determine whether Tamsolusin or Prazosin are effective in the treatment of female voiding dysfunction(BOO)